Bronte Capital Management’s Sotera Health SHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-678,512
Closed -$5.65M 31
2022
Q4
$5.65M Sell
678,512
-145,685
-18% -$1.09M 0.71% 21
2022
Q3
$5.62M Buy
824,197
+132,458
+19% +$2.2M 0.7% 22
2022
Q2
$13.6M Sell
691,739
-92,896
-12% -$1.95M 1.55% 20
2022
Q1
$17M Buy
784,635
+387,968
+98% +$8.23M 1.43% 13
2021
Q4
$9.34M Buy
396,667
+217,388
+121% +$5.2M 0.62% 19
2021
Q3
$4.69M Buy
+179,279
New +$4.34M 0.34% 19

Other funds holding SHC

Bronte Capital Management's SHC Position: Q1 2023 in Review

Bronte Capital Management sold out of Sotera Health (SHC) in Q1 2023, closing a stake of 678,512 shares — an estimated $5.65M sold.

Bronte Capital Management first reported a position in SHC in Q3 2021 and held it in 6 quarters. The position peaked at $17M in Q1 2022. 182 funds tracked by Wall St. Rank hold SHC as of Q1 2023.

  • Bronte Capital Management reported no remaining Sotera Health position as of Q1 2023 after selling out during the quarter.
  • Bronte Capital Management sold 678,512 Sotera Health shares in Q1 2023, an estimated $5.65M.
  • Bronte Capital Management first reported a position in Sotera Health in Q3 2021 and held it in 6 quarters.
  • Bronte Capital Management's Sotera Health position peaked at $17M in Q1 2022.
  • 182 funds tracked by Wall St. Rank held Sotera Health as of Q1 2023.

Based on Bronte Capital Management's 13F filing for Q1 2023, filed 12 May 2023.